Dmytro Shymkiv: Darnytsia continues an active integration into the European pharmaceutical
Domestic pharmaceutical company Darnytsia has become a member of the Ukrainian Business and Trade Association (UBTA), whose mission is to develop an independent export-oriented Ukrainian business platform. This news was announced by Dmytro Shymkiv, the head of the Board of Directors of Darnytsia Group. According to his account, the cooperation between Darnytsia and UBTA will allow expanding business contacts with European business circles and contribute to promoting Ukrainian pharmaceutical products to the EU markets.
Dmytro Shymkiv confidently stated that Darnytsia is a European company that strictly adheres to world quality standards. Therefore, all its products meet the modern requirements of the European community for medicines. UBTA is officially authorized to represent the interests of Ukrainian exporting companies in Europe. And the bilateral cooperation between Darnytsia and UBTA will allow entering new markets with a strict system of quality standards regulation and establish closer contact with European business partners.
Shymkiv noted that by having become a member of UBTA, the Darnytsia company had an opportunity to join the discussion initiated by this business association in terms of the opening of the EU market for Ukrainian drug manufacturers. This important event was held with the Ministry of Economic Development, Trade and Agriculture of Ukraine, the Ministry of Public Health, the Trade Representative of Ukraine, and the State Expert Center. Important issues were raised for discussions at the meeting, like eliminating double checks of Ukrainian pharmaceutical manufacturers for compliance with Good Manufacturing Practices (GMP) requirements and the need for mutual recognition of GMP certificates by Ukraine and EU member states.
Dmytro Shymkiv also recalled that earlier, in February 2021, Darnytsia became a member of the largest global organization of specialists regulating healthcare and related products (medicines, medical products, biotechnology, and nutritional products), The Regulatory Affairs Professionals Society (RAPS).